Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel-Reference-Cited by-同舟云学术

Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel

Published:2019-05-20 Issue:10 Volume:120 Page:17481-17490
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Zhao Weijia¹,Chen Zonghan²,Guan Meng³^ORCID

Affiliation:

1. Department of Dermatology First Affiliated Hospital of Kunming Medical University Kunming Yunnan China

2. Office of Educational Administration Yunnan University of Traditional Chinese Medicine Kunming Yunnan China

3. Department of Ophthalmology First Affiliated Hospital of Kunming Medical University Kunming Yunnan China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.29012

Reference35 articles.

1. Osteosarcomas and other cancers of bone

2. Prognostic factors in osteosarcoma: a critical review.

3. Current Treatment of Osteosarcoma

4. Adjuvant chemotherapy of high‐grade osteosarcoma of the extremity. Updated results of the Multi‐Institutional Osteosarcoma Study;Link MP;Clin Orthop Relat Res,1991

5. Neoadjuvant chemotherapy for pediatric osteosarcoma patients

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer;International Journal of Oncology;2024-06-14

2. Polydatin: A natural compound with multifaceted anticancer properties;Journal of Traditional and Complementary Medicine;2024-06

3. Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma;International Journal of Molecular Sciences;2023-08-28

4. Protective effects of polydatin against bone and joint disorders: the in vitro and in vivo evidence so far;Nutrition Research Reviews;2023-04-24

5. Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery;Cells;2023-01-04